Skip to main content
SpringerLink
Log in

Clinical trials report

  • Published:
Current Atherosclerosis Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Mehta SR, Cannon CP, Fox KA, et al.: Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. JAMA 2005, 293:2908–2917.

    Article  PubMed  CAS  Google Scholar 

  2. Fox KA, Poole-Wilson PA, Henderson RA, et al.: Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina. Lancet 2002, 360:743–751.

    Article  PubMed  CAS  Google Scholar 

  3. Pitt B, Waters D, Brown WV, et al.: Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators. N Engl J Med 1999, 341:70–76.

    Article  PubMed  CAS  Google Scholar 

  4. Hueb W, Soares PR, Gersh BJ, et al.: The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results. J Am Coll Cardiol 2004, 43:1743–1751.

    Article  PubMed  Google Scholar 

  5. Brunzell JD: Clinical practice. Hypertriglyceridemia. N Engl J Med 2007, 357:1009–1017.

    Article  PubMed  CAS  Google Scholar 

  6. Goldstein JL, Schrott HG, Hazzard WR, et al.: Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest 1973, 52:1544–1568.

    Article  PubMed  CAS  Google Scholar 

  7. Brunzell JD, Schrott HG, Motulsky AG, Bierman EL: Myocardial infarction in the familial forms of hypertriglyceridemia. Metabolism 1976, 25:313–320.

    Article  PubMed  CAS  Google Scholar 

  8. Hokanson JE, Austin MA: Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996, 3:213–219.

    Article  PubMed  CAS  Google Scholar 

  9. Frick MH, Elo O, Haapa K, et al.: Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 1987, 317:1237–1245.

    PubMed  CAS  Google Scholar 

  10. Rubins HB, Robins SJ, Collins D, et al.: Diabetes, plasma insulin, and cardiovascular disease: subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT). Arch Intern Med 2002, 162:2597–2604.

    Article  PubMed  CAS  Google Scholar 

  11. Keech A, Simes RJ, Barter P, et al.: Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 2005, 366:1849–1861.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. John A. Farmer
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Farmer, J.A. Clinical trials report. Curr Atheroscler Rep 10, 103–105 (2008). https://doi.org/10.1007/s11883-008-0015-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11883-008-0015-1

Keywords

Search

Navigation